Control of mineral metabolism and bone disease in haemodialysis patients: which optimal targets? | Zendy

Denis Fouque | Zendy; Hubert Roth | Zendy; Sandra Pelletier | Zendy; Gérard M. London | Zendy; Thierry Hannedouche | Zendy; Guillaume Jean | Zendy; Jean-Louis Bouchet | Zendy; Tilman B. Drüeke | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Control of mineral metabolism and bone disease in haemodialysis patients: which optimal targets?

Author(s) -

Denis Fouque,

Hubert Roth,

Sandra Pelletier,

Gérard M. London,

Thierry Hannedouche,

Guillaume Jean,

Jean-Louis Bouchet,

Tilman B. Drüeke

Publication year - 2012

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfs404

Subject(s) - medicine , dialysis , hazard ratio , hemodialysis , kidney disease , parathyroid hormone , proportional hazards model , renal osteodystrophy , observational study , calcium , clinical trial , urology , endocrinology , gastroenterology , confidence interval

There is a high drug treatment burden on patients receiving long-term dialysis therapy. Abnormalities of calcium and phosphate metabolism are associated with increased mortality, and attempts to correct these disturbances may improve survival.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research